Suppr超能文献

历史肌钙蛋白升高在急性心力衰竭中的意义:并不像之前假设的那样令人安心。

The significance of historical troponin elevation in acute heart failure: Not as reassuring as previously assumed.

机构信息

Department of Emergency Medicine, Indiana University School of Medicine, Indianapolis, Indiana, USA.

Department of Emergency Medicine, Wayne State University School of Medicine, Detroit, Michigan, USA.

出版信息

Acad Emerg Med. 2023 Dec;30(12):1223-1236. doi: 10.1111/acem.14798. Epub 2023 Sep 12.

Abstract

BACKGROUND

Historical cardiac troponin (cTn) elevation is commonly interpreted as lessening the significance of current cTn elevations at presentation for acute heart failure (AHF). Evidence for this practice is lacking. Our objective was to determine the incremental prognostic significance of historical cTn elevation compared to cTn elevation and ischemic heart disease (IHD) history at presentation for AHF.

METHODS

A total of 341 AHF patients were prospectively enrolled at five sites. The composite primary outcome was death/cardiopulmonary resuscitation, mechanical cardiac support, intubation, new/emergent dialysis, and/or acute myocardial infarction (AMI)/percutaneous coronary intervention (PCI)/coronary artery bypass grafting (CABG) at 90 days. Secondary outcomes were 30-day AMI/PCI/CABG and in-hospital AMI. Logistic regression compared outcomes versus initial emergency department (ED) cTn, the most recent electronic medical record cTn, estimated glomerular filtration rate, age, left ventricular ejection fraction, and IHD history (positive, negative by prior coronary workup, or unknown/no prior workup).

RESULTS

Elevated cTn occurred in 163 (49%) patients, 80 (23%) experienced the primary outcome, and 29 had AMI (9%). cTn elevation at ED presentation, adjusted for historical cTn and other covariates, was associated with the primary outcome (adjusted odds ratio [aOR] 2.39, 95% confidence interval [CI] 1.30-4.38), 30-day AMI/PCI/CABG, and in-hospital AMI. Historical cTn elevation was associated with greater odds of the primary outcome when IHD history was unknown at ED presentation (aOR 5.27, 95% CI 1.24-21.40) and did not alter odds of the outcome with known positive (aOR 0.74, 95% CI 0.33-1.70) or negative IHD history (aOR 0.79, 95% CI 0.26-2.40). Nevertheless, patients with elevated ED cTn were more likely to be discharged if historical cTn was also elevated (78% vs. 32%, p = 0.025).

CONCLUSIONS

Historical cTn elevation in AHF patients is a harbinger of worse outcomes for patients who have not had a prior IHD workup and should prompt evaluation for underlying ischemia rather than reassurance for discharge. With known IHD history, historical cTn elevation was neither reassuring nor detrimental, failing to add incremental prognostic value to current cTn elevation alone.

摘要

背景

历史上的心肌肌钙蛋白(cTn)升高通常被解释为降低了急性心力衰竭(AHF)患者当前 cTn 升高的重要性。但缺乏相关证据。我们的目的是确定与当前 cTn 升高和就诊时的缺血性心脏病(IHD)病史相比,历史上的 cTn 升高对 AHF 的预后的增量预测价值。

方法

共前瞻性纳入了 5 个地点的 341 例 AHF 患者。复合主要结局是 90 天内死亡/心肺复苏、机械心脏支持、插管、新/紧急透析和/或急性心肌梗死(AMI)/经皮冠状动脉介入治疗(PCI)/冠状动脉旁路移植术(CABG)。次要结局是 30 天内 AMI/PCI/CABG 和院内 AMI。逻辑回归比较了初始急诊(ED)cTn、最近的电子病历 cTn、估计肾小球滤过率、年龄、左心室射血分数和 IHD 病史(阳性、通过之前的冠状动脉检查为阴性或未知/无先前检查)与结果的关系。

结果

163 例(49%)患者的 cTn 升高,80 例(23%)发生主要结局,29 例发生 AMI(9%)。在调整历史 cTn 和其他协变量后,ED 就诊时的 cTn 升高与主要结局(调整后的优势比[aOR] 2.39,95%置信区间[CI] 1.30-4.38)、30 天内 AMI/PCI/CABG 和院内 AMI 相关。当 ED 就诊时 IHD 病史未知时,历史 cTn 升高与更高的主要结局风险相关(aOR 5.27,95%CI 1.24-21.40),但与已知阳性 IHD 病史(aOR 0.74,95%CI 0.33-1.70)或阴性 IHD 病史(aOR 0.79,95%CI 0.26-2.40)无关。然而,如果 ED cTn 升高,患者更有可能出院(78%比 32%,p=0.025)。

结论

在未进行先前 IHD 检查的 AHF 患者中,历史 cTn 升高是预后不良的标志,应提示评估潜在的缺血,而不是为出院提供保证。对于已知的 IHD 病史,历史 cTn 升高既不能保证也不能损害,无法为当前 cTn 升高单独提供额外的预后价值。

相似文献

1
The significance of historical troponin elevation in acute heart failure: Not as reassuring as previously assumed.
Acad Emerg Med. 2023 Dec;30(12):1223-1236. doi: 10.1111/acem.14798. Epub 2023 Sep 12.
3
The Role of Troponin for Acute Heart Failure.
Curr Heart Fail Rep. 2019 Feb;16(1):21-31. doi: 10.1007/s11897-019-0420-5.
4
Outcomes and care of patients with acute heart failure syndromes and cardiac troponin elevation.
Circ Heart Fail. 2013 Mar;6(2):193-202. doi: 10.1161/CIRCHEARTFAILURE.112.000075. Epub 2013 Feb 6.
5
EAHFE - TROPICA2 study. Prognostic value of troponin in patients with acute heart failure treated in Spanish hospital emergency departments.
Biomarkers. 2017 May-Jun;22(3-4):337-344. doi: 10.1080/1354750X.2016.1265006. Epub 2017 Jan 12.
8
Early diagnostic efficiency of cardiac troponin I and Troponin T for acute myocardial infarction.
Acad Emerg Med. 1997 Jan;4(1):13-21. doi: 10.1111/j.1553-2712.1997.tb03637.x.

本文引用的文献

2
Implementation of High-Sensitivity Cardiac Troponin Assays in the United States.
J Am Coll Cardiol. 2023 Jan 24;81(3):207-219. doi: 10.1016/j.jacc.2022.10.017. Epub 2022 Oct 31.
5
Troponin is unrelated to outcomes in heart failure patients discharged from the emergency department.
J Am Coll Emerg Physicians Open. 2022 Apr 9;3(2):e12695. doi: 10.1002/emp2.12695. eCollection 2022 Apr.
8
Use of Machine Learning to Develop a Risk-Stratification Tool for Emergency Department Patients With Acute Heart Failure.
Ann Emerg Med. 2021 Feb;77(2):237-248. doi: 10.1016/j.annemergmed.2020.09.436. Epub 2020 Dec 24.
10
The Role of Troponin for Acute Heart Failure.
Curr Heart Fail Rep. 2019 Feb;16(1):21-31. doi: 10.1007/s11897-019-0420-5.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验